Melanoma Starts Evading Treatment Within Hours – Here’s How to Stop It
ISB researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes.
Back to Previous Page
ISB News
Wei Lab
-
- All Categories
- Autoimmune Diseases
- Baliga Lab
- Brain Health
- Cancer
- Chronic Illness
- Climate Change
- Courses and Symposia
- COVID and Long COVID
- Early Detection and Diagnosis
- Education
- Environment
- Events
- Gibbons Lab
- Hadlock Lab
- Hands-on Learning
- Health
- Health Data Science Lab
- Health Equity
- Healthspan and Longevity
- Heath Lab
- Hood Lab
- Huang Lab
- Infectious Disease
- Internships
- ISB-Town Hall
- Kane Lab
- Kuchina Lab
- Logan Center for Education
- Lyme Disease
- Malaria
- Maternal and Infant Health
- Microbiome
- Moritz Lab
- Neurological Disorders
- Optimizing Outcomes
- People
- Philanthropy
- Precision Treatments
- Press Release
- Proteins and Disease
- Ranish Lab
- Real-world Science
- Research Roundtable
- Subramanian Lab
- Sustainability and Remediation
- Systemic Change
- Systems Education Experiences
- Thorsson-Shmulevich Lab
- Treatments and Resistance
- Tuberculosis
- Understanding Tumors
- Venkatesh Lab
- Wei Lab
Sort
-
- Default
- A-Z
- Z-A
- Newest
- Oldest
ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever
Dr. Wei Wei has developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.
Dr. Wei Wei Promoted to Associate Professor
Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment.
Add Fatty Acid to Taste: New Technology Reveals Single Cancer Cells Have Different Appetites for Fatty Acids
A recently developed method by the Wei Lab at Institute for Systems Biology (ISB) and University of California, Riverside provides new insights into cancer biology by allowing researchers to show how fatty acids are absorbed by single cells. This work was published in the Journal of the American Chemical Society.
Andy Hill CARE Fund Awards $100,000 to ISB Assistant Professor Dr. Wei Wei
To advance research at the intersection of COVID-19 and cancer, The Andy Hill CARE Fund has awarded ISB Assistant Professor Dr. Wei Wei a $100,000 grant to study chronic lymphocytic leukemia (CLL), one of the most commonly diagnosed leukemias in the Western world that mainly affects older individuals.
A Better Way to Find Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients
Despite the aggressive nature of Non-Small Cell Lung Cancer (NSCLC), circulating tumor cells that lead to metastases often go undetected in the blood. ISB researchers in Dr. Wei Wei’s lab and their collaborators have developed a novel method to better detect these circulating cells.